Proliferative behavior of vaginal fibroblasts from women with pelvic organ prolapse

• Published in: European journal of obstetrics & gynecology and reproductive biology 2014-12, Vol.183, p.1-4
• Main Authors: Sun, Bin, Zhou, Lu, Wen, Yan, Wang, Chenhong, Baer, Thomas M, Pera, Renee R, Chen, Bertha
• Format: Article
• Language: English
• Subjects: Adult; Age Factors; Aged; Aged, 80 and over; Biopsy; Case-Control Studies; Cell proliferation; Cell Proliferation - drug effects; Cells, Cultured; Female; Fibroblasts - drug effects; Fibroblasts - pathology; Humans; Menopause; Middle Aged; Mitotic index; Obstetrics and Gynecology; Pelvic Organ Prolapse - pathology; Premenopause; TGF-β1; Time-lapse dark-field microscopy; Transforming Growth Factor beta1 - pharmacology; Vagina - pathology; Vaginal fibroblasts
• ISSN: 0301-2115; 1872-7654
• DOI: 10.1016/j.ejogrb.2014.09.040

Abstract Objective Pelvic organ prolapse (POP) significantly impacts quality of life of women, especially with advancing age. Cell proliferation is a critical parameter in both normal and pathophysiological processes. We sought to examine fibroblast proliferation in premenopausal women with and without POP and menopausal women with POP, and examine whether TGF-β1, a fibroblast mitogen, could stimulate proliferation in vaginal fibroblasts from these populations. Study design Vaginal wall biopsies were obtained from asymptomatic women (controls) and women with POP (cases). Fibroblasts were cultured from these tissues. Vaginal fibroblasts were treated with or without TGF-β1. Cell proliferation rate (mitotic index) was measured with time-lapse dark-field microscopy. Cell mitosis was counted with ImageJ software after analysis of time-lapse images as Quick time movies. Results There was no significant difference in mitotic index throughout different time points of observation between premenopausal controls and cases of similar ages. However, a significant difference in mitotic index was seen between premenopausal and menopausal cases ( p = 0.01), with the menopausal group exhibiting significantly lower mitotic indices. When treated with different doses of TGF-β1, premenopausal control fibroblast proliferation increased with 5 ng/ml of TGF-β1 compared to non-treated fibroblasts ( p = 0.04). TGF-β1 stimulation did not affect fibroblasts from either premenopausal or menopausal cases. Conclusions Vaginal fibroblast proliferation decreases with age and this association does not appear to be affected by the presence of pelvic organ prolapse. TGF-β1 stimulation increased cell proliferation of premenopausal control fibroblasts. In contrast, there was no response seen in fibroblasts from premenopausal and menopausal cases.